Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus

Abstract Background Autoantibodies develop in autoimmune diseases, cancer, diabetes mellitus (DM), and atherosclerosis-related diseases. However, autoantibody biomarkers have not been successfully examined for diagnosis and therapy. Methods Serological identification of antigens through recombinant...

Full description

Bibliographic Details
Main Authors: Toshiki Namiki, Minoru Takemoto, Aiko Hayashi, Hiroki Yamagata, Takahiro Ishikawa, Koutaro Yokote, Shu-Yang Li, Masaaki Kubota, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Seiichiro Mine, Toshio Machida, Yoshio Kobayashi, Jiro Terada, Akira Naito, Koichiro Tatsumi, Hirotaka Takizawa, Rika Nakamura, Hideyuki Kuroda, Yasuo Iwadate, Takaki Hiwasa
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Endocrine Disorders
Subjects:
Phosphoenolpyruvate carboxykinase 1
Diabetes mellitus
Atherosclerosis
Cardiovascular disease
Antibody biomarker
Online Access:https://doi.org/10.1186/s12902-023-01491-3

Internet

https://doi.org/10.1186/s12902-023-01491-3

Similar Items